

Adding new procedures or opening a de novo center can increase volume — or quietly destroy your margins.
Most ASCs don’t fail on growth. They fail on contracts, reimbursement, and revenue cycle gaps they didn’t see coming.
This checklist shows you exactly what to pressure-test before you scale — from CPT-level profitability and payer contract readiness to chargemaster strategy, anesthesia impact, and out-of-network/IDR risk.
No fluff. Just what actually impacts cash per case.
If you’re planning growth, consider this required reading.
Sponsored by:


By downloading this content, you agree to MJH Life Sciences® Terms and Conditions, Privacy Policy, and understand your data will be used by MJH and its affiliates for amongst other things, alerting you to other services or products that you may be interested in, and may be shared with or sold to third parties for their use, including possible contact with you through email or other communications, consistent with their respective privacy policy. If you do not agree to have your data used in this way, please contact info@mjhassoc.com.